| MDL | MFCD30470660 |
|---|---|
| Molecular Weight | 389.43 |
| Molecular Formula | C22H20FN5O |
| SMILES | N#CC1=C(C2=CC3=C(C(N([C@@H](CC4=CC=CC(F)=C4)CN)C3)=O)C=C2)N(C)N=C1 |
AKT-IN-6 (Example 13) is a potent Akt inhibitor . AKT-IN-6 inhibits Akt1 , Akt2 and Akt3 with IC 50 s < 500nM, respectively. (patent WO2013056015A1).
|
Akt1 |
Akt2 |
Akt3 |
Akt is a central node in cell signaling downstream of growth factors, cytokines, and other cellular stimuli. Aberrant loss or gain of Akt activation underlies the pathophysiological properties of a variety of complex diseases, including type-2 diabetes and cancer [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 125 mg/mL ( 320.98 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.5679 mL | 12.8393 mL | 25.6786 mL |
| 5 mM | 0.5136 mL | 2.5679 mL | 5.1357 mL |
| 10 mM | 0.2568 mL | 1.2839 mL | 2.5679 mL |